A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Transformation and causes of death in follicular lymphoma: A Finnish nationwide population‐based study




TekijätKalashnikov, Ilja; Reunamo, Taina; Tanskanen, Tomas; Viisanen, Leevi; Malila, Nea; Jyrkkiö, Sirkku; Leppä, Sirpa

KustantajaWiley-Blackwell

Julkaisuvuosi2025

Lehti: British Journal of Haematology

Artikkelin numerobjh.70181

ISSN0007-1048

eISSN1365-2141

DOIhttps://doi.org/10.1111/bjh.70181

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Osittain avoin julkaisukanava

Verkko-osoitehttps://doi.org/10.1111/bjh.70181

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/504556157


Tiivistelmä

Follicular lymphoma (FL) is a common, indolent lymphoma, and patients with FL typically have a good prognosis. However, they may experience histological transformation into aggressive large B-cell lymphoma. We conducted a nationwide population-based study to estimate the risk of transformation in FL, considering different FL grades, and studied the relative survival (RS) of patients diagnosed with FL in Finland from 1995 to 2018. We identified a total of 4014 patients with newly diagnosed grade 1–3A FL. The median age at diagnosis was 64 years, and 55% of patients were female. The cumulative incidence of transformation across the entire cohort was 8.4% at 10 years (95% confidence interval [CI], 7.5–9.5). The 10-year RS was 78% for the whole cohort and showed improvement over time. Transformation was associated with a significantly increased risk of death (hazard ratio [HR] 5.0; 95% CI, 4.2–6.0; p < 0.001). Grade 3A was associated with higher excess mortality compared to patients with low-grade FL. Lymphoma was the most common cause of death. We conclude that, although the 10-year RS was relatively good, grade 3A FL and transformation led to significantly higher mortality compared to low-grade FL or no transformation. Our results also indicate a reduction in excess mortality over time.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
This research was funded by grants from the Academy of Finland (SL), Finnish Cancer Organizations (SL), Sigrid Juselius Foundation (SL), University of Helsinki (SL), Helsinki University Hospital (SL), Finnish Society for Oncology (IK and TR) and Turku University Hospital (TR). Open access publishing facilitated by Helsingin yliopisto, as part of the Wiley - FinELib agreement.


Last updated on 2025-31-10 at 13:45